Concepedia

Author

Chenglong Liu

Fudan UniversityORCID

Also Known As

Cheng-long Liu, Chenglong Liu

22

Publications

746

Citations

11

H-Index

24

Concepts

All Affiliations

Fudan UniversityChinese Academy of SciencesShanghai Institute of Materia MedicaUniversity of Chinese Academy of SciencesShanghai Institutes for Biological Sciences
CL

About

Chenglong Liu is an author at Fudan University specializing in cell biology, medicine, and cancer cell biology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

4

4

331

2

Cell Biology

4

4

331

3

Immunology

2

2

270

4

Pathology

1

1

239

5

Pharmacology

1

1

49

Chenglong Liu

×

9

Publications

635

Citations

9

H-Index

YearCitations

Single-cell transcriptome analysis reveals tumor immune microenvironment heterogenicity and granulocytes enrichment in colorectal cancer liver metastases

Yunbin Zhang, Jingjing Song, Zhongwei Zhao,

Cancer Letters

2019

239

IFNα Potentiates Anti–PD-1 Efficacy by Remodeling Glucose Metabolism in the Hepatocellular Carcinoma Microenvironment

Bo Hu, Mincheng Yu, Xiaolu Ma,

Cancer Discovery

2022

192

Targeting Wnt/β-Catenin Pathway for Drug Therapy

Chenglong Liu, Kohichi Takada, Di Zhu

Medicine in Drug Discovery

2020

49

RORγt agonist enhances anti-PD-1 therapy by promoting monocyte-derived dendritic cells through CXCL10 in cancers

Li Xia, Enming Tian, Mingcheng Yu,

Journal of Experimental & Clinical Cancer Research

2022

39

BCL9 regulates CD226 and CD96 checkpoints in CD8+ T cells to improve PD-1 response in cancer

Mei Feng, Zhongen Wu, Yan Zhou,

Signal Transduction and Targeted Therapy

2021

38

RORγt agonist synergizes with CTLA-4 antibody to inhibit tumor growth through inhibition of Treg cells via TGF-β signaling in cancer

Enming Tian, Mingcheng Yu, Mei Feng,

Pharmacological Research

2021

31

Discovery of a novel, potent and selective small‐molecule inhibitor of PD‐1/PD‐L1 interaction with robust <i>in vivo</i> anti‐tumour efficacy

Chenglong Liu, Feilong Zhou, Ziqin Yan,

British Journal of Pharmacology

2021

23

Discovery of a selective and covalent small-molecule inhibitor of BFL-1 protein that induces robust apoptosis in cancer cells

Xuexin Feng, Ziqin Yan, Feilong Zhou,

European Journal of Medicinal Chemistry

2022

12

Discovery of Novel 3-Phenylpiperidine Derivatives Targeting the β-Catenin/B-Cell Lymphoma 9 Interaction as a Single Agent and in Combination with the Anti-PD-1 Antibody for the Treatment of Colorectal Cancer

Hao Zhang, Chenglong Liu, Qiushi Chen,

Journal of Medicinal Chemistry

2023

12

Page 1